The Complex Relationship of Cmv Igm, Pp65 Antigenemia, Plasma, and Cellular Hcmv Q-Pcr As Observed in an Immunocompetent Population and in Hsct Patients

Fang Fengqin,Mao Kezi,Zhang Li,Yang Zhijun,Hu Jiong,Lu Yide,Wang Xianghui,Ji Yuhua
DOI: https://doi.org/10.1309/lmu62g9yadogjeqf
IF: 1.865
2010-01-01
Laboratory Medicine
Abstract:Objective: The complex correlation among 4 tests including CMV IgM, pp65 antigenemia, plasma, and cellular human cytomegalovirus (HCMV) Q-polymerase chain reaction (PCR) has not been thoroughly illustrated due to the deficiency of related basic research; a circumstance that greatly hindered the choice of the best method with which to detect HCMV productive replication for clinical use.Materials and Methods: In this article, 2 study populations, 1 immune competent and the other immune suppressed, were enrolled to analyze the intricate relationship among them using a cross-sectional and longitudinal study.Results: It was found that the degree of agreement between plasma and cellular Q-PCR was always greatest among the tests. In the immunocompetent population, co-positive samples achieved 20.31% in the positive results of cellular Q-PCR and 59.09% in plasma Q-PCR, while the Pearson correlation coefficient (PCC) was 0.3056 (P=0.0001). In the human cytomegalovirus (HSCT) patients, most of the results showed plasma and cellular Q-PCR under the same detected reactivation-episodes with the latter being more sensitive than the former in 84.62% of episodes (22/26). As for the group of pp65 antigenemia and cellular Q-PCR, the agreement was weak in the healthy population (co-positive samples occupied 26.47% in the former with positive results and 14.06% in the latter, while PCC was 0.1024 [P=0.0245]), even though the situation was better in HSCT recipients. However, nearly half of the episodes showed that pp65 antigenemia testing was more sensitive than cellular Q-PCR (17.65%, 3/17) or both of them were not under the same detected CMV-reactivation episodes (23.53%, 4/17).Conclusions: The risk of replacing plasma Q-PCR by cellular Q-PCR should not overcome the benefit of doing so. However, pp65 antigenemia and cellular Q-PCR have complementary characteristics, and it appears that the value of combining these 2 tests would be greater than the value of any single method in clinical use.
What problem does this paper attempt to address?